Great Debates and Updates in GI Malignancies Continuing Medical Education Opportunity

Share Article

For more information and to register for Great Debates and Updates in GI Malignancies on March 30-31, 2012 in New York, New York please contact us: E-mail us at registration(at)imedex(dot)com Call us at 1-855-276-6855 Or Register online at http://www.greatdebatesingimalignancies.com - About Imedex, LLC Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

News Image

Past News Releases

RSS

Imedex, LLC presents Great Debates and Updates in GI Malignancies to be held on March 30-31, 2012 in New York, New York. This continuing medical education (CME) opportunity has a target audience of gastrointestinal oncologists, medical oncologists, gastroenterologists, radiation oncologists, gastrointestinal surgeons, pathologists, and other physicians in active clinical practice, or interested in the diagnosis, treatment, and management of patients with GI malignancies.

This oncology CME opportunity will feature a “Meet the Experts” lunch, which will allow attendees and faculty presenters the opportunity to interact during lunch on Friday and Saturday in a relaxed, yet informative setting. The cutting-edge interactive format of this presentation will provide speakers and audience members the ability to exchange information through a “hands-on” computerized speaker-audience interaction system. During this gastroenterology CME meeting participants will be able to answer multiple-choice questions and their answers will be calculated and projected on a screen in tabular or graphic form for all to see. This system allows attendees from diverse disciplines to compare viewpoints and debate or build consensus between the speakers and each other.

Some topics for discussion during this oncology CME opportunity will include:

  •     Colorectal cancer
  •     Pancreatic cancer
  •     Gastroesophageal cancers
  •     GIST
  •     Biliary tract cancer
  •     Neuroendocrine tumors
  •     Hepatocellular carcinoma

Upon successful completion of this continuing medical education opportunity, attendees can expect to:

  •     Demonstrate increased knowledge regarding:

o    The significance and utilization of at least one prognostic or predictive biomarker in colorectal and gastric cancers

  •     Feel more confident in their ability to:

o    Select a therapy based upon biomarker test analysis
o    Discuss the current and future role of biologic and targeted therapies in managing GI cancers
o    Recommend the most appropriate adjuvant or neoadjuvant therapy regimen for patients with GI cancer
o    Summarize the role of radiotherapy in GI malignancies
o    Suggest optimal therapeutic algorithms based upon current and emerging data

For more information and to register for Great Debates and Updates in GI Malignancies on March 30-31, 2012 in New York, New York please contact us:

        E-mail us at registration(at)imedex(dot)com
        Call us at 1-855-276-6855
        Or
        Register online at http://www.greatdebatesingimalignancies.com

For event updates, and more information about this exciting cme event connect with us! Find us on:

        Facebook at https://www.facebook.com/pages/Great-Debates-in-GI-Malignancies/226041580788640
        Twitter @Gimalignancycme

For more Imedex events and updates, visit our blog at http://oncologycme.tumblr.comor got to http://www.imedex.com

Key Terms: Hematology CME, Oncology CME, Gastroenterology CME, Medical Oncology, Radiation Oncology. Pathology CME. Pharmacy CME, Residency Fellowship CME, and Oncology Nurse CE

About Imedex, LLC
Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.

Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, we believe that education is the best medicine. ®

Release issued by Audience Generation, LLC
Audience Generation is a forward thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social and mobile audiences where they exist on demand.

Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience where they exist in person, online, via social networks or on their mobile devices.

Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture backed start-up companies across a variety of industry verticals around the World.

To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand and grow your bottom line please call us at 512-708-4678 or email us at growyourbusiness(at)audiencegeneration(dot)com or visit us at: http://www.audiencegeneration.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Marilyn Holman
Audience Generation
512-708-4678
Email >
Visit website